DNA Methylation in Alzheimer's Disease
Luke Weymouth1, Adam R Smith1, Katie Lunnon2
1Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Current Topics in Behavioral Neurosciences
|October 25, 2024
Summary
DNA methylation, an epigenetic change, is key in Alzheimer's disease research. Studies show it can silence genes and may link environmental factors to disease, offering new insights into Alzheimer's mechanisms.
Area of Science:
- Neuroscience
- Epigenetics
- Genomics
Background:
- DNA methylation is the most studied epigenetic modification in Alzheimer's disease (AD).
- It involves adding a methyl group to cytosine, typically silencing gene expression.
- Epigenetic mechanisms like DNA methylation may mediate gene-environment interactions in AD.
Purpose of the Study:
- To comprehensively review epigenomic studies on Alzheimer's disease.
- To focus on DNA methylation's role in human brain tissue and cell types.
- To highlight key differentially methylated genes and pathways in AD.
Main Methods:
- Review of epigenomic studies in human brain tissue and purified brain cell types.
- Analysis of global methylation levels, candidate genes, and epigenome-wide association studies (EWAS).
- Inclusion of recent meta-analyses and discussion of emerging technologies.
Main Results:
- Identified key differentially methylated genes and pathways implicated in Alzheimer's disease.
- Summarized findings from global methylation, candidate gene, and EWAS approaches.
- Highlighted the significance of DNA methylation in understanding AD pathogenesis.
Conclusions:
- DNA methylation is a critical epigenetic factor in Alzheimer's disease.
- Further research integrating multiomic data and new technologies will advance understanding of AD epigenomics.
- Investigating DNA methylation offers potential for novel therapeutic strategies in AD.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
01:23Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456
01:30Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97